Intramuscular versus vaginal administration of progesterone for luteal phase support after in vitro fertilization and embryo transfer. A comparative randomized study

Clinical and Experimental Obstetrics and Gynecology

Volumn 26, Issue 3-4, 1999, Pages 203-206

  Abate, A ^a   Perino, M ^a   Abate, F G ^a   Brigandi A ^a   Costabile, L ^a,b   Manti, F ^a  

^a Center of Human Reproduction   (Italy)

^b NONE   (Italy)

Author keywords

Intramuscular progesterone; IVF; Luteal phase supplementation; Vaginal gel progesterone

Indexed keywords

ESTRADIOL; PROGESTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; PREGNANCY; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INTRAVAGINAL; ADULT; EMBRYO TRANSFER; ESTRADIOL; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; LUTEAL PHASE; PREGNANCY; PREGNANCY MAINTENANCE; PROGESTERONE;

EID: 0033402020     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Medical Research International: "The American Fertility Society Speical Interest Group: in vitro fertilization/embryo transfer in the United States: 1985 and 1986 results from the National IVF/ET registry". Fertil. Steril., 1988, 49, 212.
2. IFFS World Collaborate Report. 1993.
3. Leeton J., Trounson A., Jessup D.: "Support of luteal phase in vitro fertilization programs: results of a controlled trial with intramuscular proluton". J. In Vitro Fert. Embryo Transfer., 1985, 2, 166.
4. Van Steirteghem A.C., Smitz J., Camus M., Van Waeberghe L , Descharcht J., Khan I. et al : "The luteal phase in vitro fertilization and related procedure". Hum Reprod., 1988, 3, 161.
5. Wong Y. F., Loong E. P. L., Mao K. R., Tam P. L., Panesur N. S., Neale E. et al., "Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens". Reprod, Fertil Dev., 1999, 2, 351.
6. Soliman S., Daya S , Collius J. and Hughes E. G.: "The role of luteal phase in infertility treatment: a meta-analysis of randomized trials". Fertil. Steril., 1994, 61. 1068
7. Csapo A. L., Pulkkinen M. O., Ruttner B., Sauvage J. P., Wlest W. G.: "The significance of human corpus luteum in pregnancy maintenance". Am J. Obstet. Gynecol., 1972, 112, 1061.
8. Kinel F A., Claccio L. A. "Suppression of immune response by progesterone". Endocrinol. Exp., 1980, 14, 27.
9. Garcia J. E., Jones H. W., Acosta A A., Wright G.: "Corpus luteum function after follicle aspiration for occyte retrieval". Fertil Steril., 1981, 36, 565.
10. Casper R., Wilson E , Collins J.: "Enhancement of human implantation by exogenous chorionic gonadotrophin". Lancet, 1983, 2, 1191.
11. Gibbons W. E., Toner J. P., Hamacher P., Kohn P.: "Experience with a novel vaginal progesterone preparation in a donor oocyte program", Fertil. Steril., 1998, 69, 96.
12. Arafat E. S., Hargrove J. T., Maxson W. S., Desiderio D. M., Wentz A C., Andersen R. N.: "Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites". Am. J. Obstet. Gynecol., 1988, 159, 1203.
13. Smitz J., Devray P., Faguer B., Bourgain C., Camus M., Van Steirteghem A. C.: "A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement". Hum. Reprod., 1992, 7, 168.
14. Keith S. C., London S. N., Weitzman G. A., O'Brien T. J., Miller M. M.: "Serial transvaginal ultrasound scans and ß-human chorionic gonadotropin levels in early singleton and multiple pregnancies". Fertil. Steril., 1993, 59, 1007.
15. Vye P., Pouly J. L., Canis M. et al.: "Phase luteàle lors fécondation in vitro après stimulation par HMG associées aux analogues du LHRH". Contraceft. Fertil. Sex., 1989, 17, 913.
16. Sauer M. V., Paulson R. J., Macaso T. M., Francis-Hernand M., Lobo R. A.: "The establishment of a nonanonymous donor oocyte program: preliminary experience at the university of Southern California". Fertil. Steril., 1989, 61, 1212.
17. Bourgain C., Smitz J., Camus M. et al.: "Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin releasing hormone analogue/human menopausal gonadotropin stimulated cycle". Hum. Reprod., 1994, 9, 32.
18. Licciardi F. L., Kwiatowski A., Noyes N. L. et al., "Oral versus intramuscular progesterone for in vitro fertilitation a prospective randomized study". Fertil. Steril., 1999, 71, 614.
19. Wilson M. A.: "GABA physiology: modulation by benzodiazepines and hormones". Crit. Rev. Neurobiol., 1996, 10, 1.
20. Perusquia M., Villalon C M.: "The relaxant effect of sex steroids in rat myometrium is independent of the gammaamino butyric acid system". Life Sci, 1996, 58, 913.
21. Simon J. A., Robinson D. E., Andrews M C. et al.: "The absorption of oral micronized progesterone: the effect of food. dose, proportionally and comparison with intramuscular progesterone". Fertil. Steril., 1993, 60, 26.
22. Navot D., Andersen T. L., Drocsch K., Scott R. T., Kreiner D., Rosenwaks Z.: "Hormonal manipulation of endometrial maturation". J. Clin Endocrinol. Metab., 1989, 68, 801.
23. Pouly J. L., Bassil S., Frydman R., Hedon B., Nicollet B., Prada Y., Antoine J. M. et al.: "Luteal support after in vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone". Hum. Reprod . 1996, 11, 2085.
24. Miles R. A., Paulson R. J., Lobo R. A., Press M. F., Dahmoush L., Sauer M. V.: "Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes. A comparative study" Fertil. Steril., 1994, 62, 485.
25. Franchin R., De Ziegler D., Bergeron C., Righini C., Torrisi C., Frydman R : "Transvaginal administration of progesterone". Obstet. Gynecol., 1997, 90, 396.
26. Nillius S. J., Johansson E.D.B.: "Plasma levels of progesterone after vaginal. rectal, or intramuscular administration of progesterone". Am. J. Obstet. Gynecol., 1971, 110, 470.
27. Maraschio F., Soagnolo G., Sbano E., De Marines S., Magri B.: "Confronto fra tre differenti schemi terapeutici di supplementazione della fase luteale in cicli di fecondazione assistita". Atti della Società Italiana di Ginecologia e Ostetricia, 1996.
28. Wang H. S., Soong Y. K.: "Transvaginal progesterone supplementation increases serum insulin-like growth factor-binding protein-1 levels". Gynecol. Endocrinol., 1996, 10, 349.